Drug interactions
Dichlorphenamide + Insulin glulisine
Severity: Moderate
Dichlorphenamide and Insulin glulisine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dichlorphenamide is a carbonic anhydrase inhibitor that causes renal potassium wasting and can produce hypokalemia and metabolic acidosis. Insulin also drives potassium into cells, so combined use can lower serum potassium further.
What this interaction means in plain words
Dichlorphenamide and Insulin glulisine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Dichlorphenamide belongs to Miscellaneous; Insulin glulisine belongs to Endocrine.
Why it happens
Additive potassium lowering through increased renal potassium loss (dichlorphenamide) and insulin-mediated cellular potassium uptake.
What to do
Measure serum potassium and bicarbonate at baseline and periodically during combined therapy. Correct hypokalemia promptly and monitor glucose.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dichlorphenamide and Insulin glulisine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Insulin glulisine
Other interactions of Dichlorphenamide
Frequently asked questions
Can I take Dichlorphenamide with Insulin glulisine?
MediHelp rates the interaction as moderate. Dichlorphenamide and Insulin glulisine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dichlorphenamide is a carbonic anhydrase inhibitor that causes renal potassium wasting and can produce hypokalemia and metabolic acidosis. Insulin also drives potassium into cells, so combined use can lower serum potassium further.
How serious is the interaction between Dichlorphenamide and Insulin glulisine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Measure serum potassium and bicarbonate at baseline and periodically during combined therapy. Correct hypokalemia promptly and monitor glucose.
What other medicines interact with Insulin glulisine?
MediHelp also lists interactions of Insulin glulisine with, for example, Alogliptin-pioglitazone, Ethanol, Pentamidine. The full list is on the Insulin glulisine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
